The Medical CBRN Defense Consortium (MCDC),
CoV Pandemic Response Request for Information
is seeking white papers for solutions to the novel Coronavirus (2019-nCoV) pandemic in the following areas: diagnostics/monitoring, surveillance, information systems for point of care, therapeutics, prophylactics, and clinical trials. While white papers will be accepted through May 31, MCDC is requesting them by 4 pm on March 21, 2020 due to the urgency of the situation.
The National Institutes of Health have issued a
Notice of Special Interest (NOSI)
to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.
Researchers may request supplemental funding (
) or as an Urgent Competitive Revision (
) to an existing grant.
Amyotrophic Lateral Sclerosis Research Program, Autism Research Program, and Ovarian Cancer Research Program
Due to impacts of COVID-19, the Amyotrophic Lateral Sclerosis Research Program (ALSRP), Autism Research Program (ARP), and Ovarian Cancer Research Program (OCRP) have extended the pre-application submission deadline. The extension is for all applicants.
Requests for further extensions to the new pre-application submission deadlines will not be accepted. The FY20 ALSRP released funding opportunities on January 17, 2020. The FY20 ARP and FY20 OCRP released funding opportunities on February 27, 2020.